Archives of pharmacal researchHumansBreast NeoplasmsFemaleReceptorsEstrogen
Advances and challenges of estrogen receptor-targeted agents in breast cancer.
Jie Hu, Songyang Zhong, Huayu Sun, Jie Liu, Wentong Fang
Published: 202510.1007/s12272-025-01583-9
Abstract
Estrogen receptors (ERs) are expressed in approximately 70% of breast cancer patients and serve as pivotal therapeutic targets. ER-targeting agents like selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs)…
Preview only. Read the full abstract at the source